Biotech Firm, Gambling Software Co. Prep IPOs Totaling $83M
A biotechnology firm developing therapies for ear, nose and throat disorders and a U.K. maker of gambling software on Monday set pricing terms for U.S. initial public offerings that could raise...To view the full article, register now.
Already a subscriber? Click here to view full article